Comparative Effects of Aerobic and Muscle Relaxation Exercises in Pregnant Women With Restless Leg Syndrome
Comparative Effects of Aerobic and Muscle Relaxation Exercises to Improve Sleep Quality, Fatigue Level, Pain Intensity and Quality of Life in Pregnant Women With Restless Leg Syndrome
調査の概要
詳細な説明
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Imran Amjad, PhD
- 電話番号:03324390125
- メール:imran.amjad@riphah.edu.pk
研究場所
-
-
Punjab Province
-
Lahore、Punjab Province、パキスタン、54770
- 募集
- Valencia health clinic
-
主任研究者:
- Sadia Gulzar, MSWHPT
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Pregnant women diagnosed with Restless Leg Syndrome based on clinical criteria.
- Gestational age between 20 to 34 weeks.
- Age range between 20-40 years.
- Experiencing moderate to severe sleep disturbance as per Pittsburgh Sleep Quality Index (PSQI score >5).
- Complaints of fatigue and generalized discomfort during pregnancy.
Exclusion Criteria:
High-risk pregnancy or obstetric complications (e.g., preeclampsia, placenta previa).
- History of neurological or musculoskeletal disorders unrelated to pregnancy.
- Any psychiatric disorder or currently taking sedative medications.
- History of uncontrolled diabetes mellitus or thyroid dysfunction.
- Participation in any structured exercise program or physiotherapy within the last 3 months.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:aerobic exercises
supervised aerobic exercises (brisk walking, cycling, step-ups, etc.) 3 times a week for 8 weeks
|
Participants in Group A will receive supervised aerobic exercise in addition to conventional therapy.
Mode: Treadmill walking or stationary cycling (based on participant preference and safety).
Intensity: Moderate intensity at 50-60% of maximum heart rate (HRmax), calculated as HRmax = 220 - age.
Duration: 30 minutes per session.
Frequency: 3 sessions per week.
Total Duration: 8 weeks.
Monitoring: Heart rate monitors will be used to ensure target heart rate is maintained.
Each session will be supervised by a qualified physiotherapist.
Warm-up and Cool-down: 5-minute warm-up and 5-minute cool-down before and after each session.
|
|
実験的:progressive muscle relaxation
progressive muscle relaxation sessions of 20- 25 minutes, also 3 times a week for 8-weeks.
|
Participants in Group B will receive supervised progressive muscle relaxation (PMR) in addition to conventional therapy. Muscle Groups: 16 major muscle groups will be targeted sequentially, including feet, calves, thighs, hips, abdomen, chest, arms, hands, shoulders, neck, jaw, eyes, forehead, and face. Technique: Each muscle group will be tensed for 5-7 seconds followed by relaxation for 20-30 seconds. Duration: 30 minutes per session. Frequency: 3 sessions per week. Total Duration: 8 weeks. Monitoring: Sessions will be conducted under supervision to ensure proper technique and participant comfort. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Pittsburgh Sleep Quality Index
時間枠:8 weeks
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI).
This self-rated questionnaire evaluates sleep quality over a 1-month period.
It includes 19 items generating seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.
These components are summed to yield a global PSQI score ranging from 0 to 21.
A score greater than 5 indicates poor sleep quality.
(39)
|
8 weeks
|
|
Fatigue Severity Scale
時間枠:8 weeks
|
Fatigue levels will be assessed using the Fatigue Severity Scale (FSS). The scale includes 9 statements rated on a 7-point Likert scale, where higher scores indicate greater fatigue severity. The scale focuses on the impact of fatigue on motivation, exercise, physical functioning, and social life. |
8 weeks
|
|
Numerical Pain Rating Scale
時間枠:8 weeks
|
Pain intensity will be measured using the Numerical Pain Rating Scale (NPRS), a scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Participants will rate their average pain during the past week.
|
8 weeks
|
|
WHOQOL-BREF (Quality of Life)
時間枠:8 weeks
|
Quality of life will be assessed using the WHOQOL-BREF questionnaire.
It consists of 26 items covering four domains: physical health, psychological health, social relationships, and environment.
Higher scores represent better quality of life.
|
8 weeks
|
協力者と研究者
捜査官
- 主任研究者:Hafiza Iqra Rubab, MSWHPT、Riphah International University
出版物と役立つリンク
一般刊行物
- Mislu E, Assalfew B, Arage MW, Chane F, Hailu T, Tenaw LA, Kidie AA, Kumsa H. Prevalence and factors associated with restless legs syndrome among pregnant women in middle-income countries: a systematic review and meta-analysis. Front Med (Lausanne). 2023 Dec 21;10:1326337. doi: 10.3389/fmed.2023.1326337. eCollection 2023.
- Dewald-Kaufmann J, de Bruin E, Michael G. Cognitive Behavioral Therapy for Insomnia in School-Aged Children and Adolescents. Sleep Med Clin. 2022 Sep;17(3):355-365. doi: 10.1016/j.jsmc.2022.06.003.
- Luo Y, Du J, Wang J, Liu P, Shi Z, He Y, Che G, Huang K, Wang J. Progressive muscle relaxation alleviates anxiety and improves sleep quality among healthcare practitioners in a mobile cabin hospital: a pre-post comparative study in China. Front Psychol. 2024 Apr 30;15:1337318. doi: 10.3389/fpsyg.2024.1337318. eCollection 2024.
- Sweet L, O'Driscoll K, Blums T, Sommeling M, Kolar R, Teale G, Wynter K. Relationships are the key to a successful publicly funded homebirth program, a qualitative study. Women Birth. 2023 Jul;36(4):377-384. doi: 10.1016/j.wombi.2022.12.005. Epub 2023 Jan 4.
- Khan IA, Khan M, Raza F, Sheikh MLJMJoN. Enhancing Management of Restless Legs Syndrome through Complementary Physical Therapy: Toward Better Outcomes in a Distressing Sensorimotor Disorder. 2025;9(1):1-17.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- REC/RCR & AHS/25/0511
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。